IL-6 receptor drugs for COVID-19
3 tracked IL-6 receptor drugs in the COVID-19 race. The class explanation lives on the IL-6 receptor page; the full indication pipeline across every mechanism is on the COVID-19 page.
2 approved / phase 41 Phase 3
Head-to-head evidence: BAT1806 vs tocilizumab · Levilimab vs tocilizumab